Stay updated on Nivolumab and Plinabulin in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.

Latest updates to the Nivolumab and Plinabulin in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3. This appears to be a minor maintenance update that does not alter the study details or user-visible content.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2. This signals a backend/frontend maintenance update without altering the displayed study details.SummaryDifference0.1%

- Check31 days agoChange DetectedNew help and navigation items were added to the page: No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment section label, while the older Intervention / Treatment label was removed. The revision badge changed from Revision: v3.5.5 to Revision: v3.6.0.SummaryDifference0.5%

- Check38 days agoChange DetectedThe page revision tag was updated to v3.5.5, indicating a newer version of the entry has been published.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a new page build. It does not modify the study details themselves.SummaryDifference0.1%

- Check81 days agoChange DetectedClinicalTrials.gov page footer revision updated from v3.5.2 to v3.5.3, indicating a platform/build version change rather than substantive study information.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Plinabulin in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.